Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Human biodistribution of sup 111 In-labeled B72. 3 monoclonal antibody

Journal Article · · Cancer Research; (USA)
OSTI ID:7026480

The murine IgG1 monoclonal antibody B72.3 reacts with human colorectal, breast, lung, pancreatic, gastric, and ovarian tumors. Human biodistribution studies using intact {sup 131}I-B72.3 have been reported by Carrasquillo et al.. We have performed similar studies on five patients using i.v. infusion of 20 mg of intact {sup 111}In-B72.3 (Cytogen Corp.). Serum clearance is similar with a t1/2 of 64.2 h (range, 44-80) for {sup 111}In-B72.3 and 65 h (range, 32-106) for {sup 131}I-B72.3. However, organ biodistribution is markedly different. For {sup 131}I-B72.3, hepatic and splenic clearance mirrors blood pool clearance. For {sup 111}In-B72.3, there is rapid uptake in tumor, liver, spleen, kidney, lumbar spine, and testes by 2-6 h with no significant clearance over the next 9 days. For {sup 111}In-B72.3, quantitative analysis of liver (from biopsy specimens), spleen, kidney, and lumbar spine (from scintiphoto regions of interest after background subtraction and attenuation correction) shows the following peak organ biodistributions in percentage infused dose: liver, 32%; spleen, 3.9%; kidneys, 3.5%; and lumbar vertebral bodies (marrow sample), 2.7%. For both {sup 111}In-B72.3 and {sup 131}I-B72.3, the principal route of excretion from the body is urinary with excretion rate of {sup 131}I faster than {sup 111}In. The marked differences between {sup 111}In-B72.3 and {sup 131}I-B72.3 biodistribution and clearance strongly influence the dosimetry, immunodetection, and immunotherapeutic potentials of B72.3 MoAb.

OSTI ID:
7026480
Journal Information:
Cancer Research; (USA), Journal Name: Cancer Research; (USA) Vol. 50; ISSN CNREA; ISSN 0008-5472
Country of Publication:
United States
Language:
English

Similar Records

Differences in biodistribution of indium-111-and iodine-131-labeled B72. 3 monoclonal antibodies in patients with colorectal cancer
Journal Article · Tue Feb 28 23:00:00 EST 1989 · J. Nucl. Med.; (United States) · OSTI ID:5601984

Pharmacokinetics of the monoclonal antibody B72. 3 and its fragments labeled with either /sup 125/I or /sup 111/In
Journal Article · Sat Feb 14 23:00:00 EST 1987 · Cancer Res.; (United States) · OSTI ID:6702939

Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72. 3 monoclonal antibody
Journal Article · Wed Jun 01 00:00:00 EDT 1988 · J. Nucl. Med.; (United States) · OSTI ID:6924236